Stemline Therapeutics Announces Presentation of ELZONRIS (tagraxofusp) Preclinical Data in Systemic Sclerosis, an Autoimmune Disorder, at EULAR Congress

Ads

You May Also Like

Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock

VANCOUVER, British Columbia, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...